[1]
K. K. Y. Kouassi, “Trastuzumab and Pertuzumab in HER2-Positive Metastatic Breast Cancer in West Africa: A Retrospective Cohort Study from Côte d’Ivoire: Study HER2-Breast-CIV”, Arch Breast Cancer, vol. 12, no. 4, pp. 419–425, Oct. 2025.